Supplementary Table 1.docx (11.94 kB)

Supplementary Table 1: Anticoagulation and BMI: effect of high body weight on the safety and efficacy of direct oral anticoagulants.docx

dataset

posted on 2022-09-02, 09:54 authored by Kyle G Mausteller, Caroline D Eisele, Katherine Julian, Puja PatelPuja Patel, Amit Bansal, Rahul Jain, Rohit JainRohit Jain

Supplemental Table 1. Summary of clinical trials on apixaban and rivaroxaban efficacy and safety in obese populations

History

Usage metrics

Keywords

anticoagulation apixaban obesity oral anticoagulants pharmacokinetics rivaroxaban venous thromboembolism

Licence

CC BY-NC-ND 4.0

Supplementary Table 1: Anticoagulation and BMI: effect of high body weight on the safety and efficacy of direct oral anticoagulants.docx

History

Usage metrics

Categories

Keywords

Licence

Exports